Influence of Pathogenic and Metabolic Genes on the Pharmacogenetics of Mood Disorders in Alzheimer's Disease

• المؤلفون الرئيسيون: Ramón Cacabelos (مؤلف), Juan C. Carril (مؤلف), Lola Corzo (مؤلف), Lucía Fernández-Novoa (مؤلف), Rocío Pego (مؤلف), Natalia Cacabelos (مؤلف), Pablo Cacabelos (مؤلف), Margarita Alcaraz (مؤلف), Iván Tellado (مؤلف), Vinogran Naidoo (مؤلف)
• التنسيق: كتاب
• منشور في: MDPI AG, 2021-04-01T00:00:00Z.
• الموضوعات: article
• الوصول للمادة أونلاين: Connect to this object online.

Background: Mood disorders represent a risk factor for dementia and are present in over 60% of cases with Alzheimer's disease (AD). More than 80% variability in drug pharmacokinetics and pharmacodynamics is associated with pharmacogenetics. Methods: Anxiety and depression symptoms were assessed...